Global Biopharmaceutical CMO & CRO Market Insights and Forecast to 2028

Report ID: 1548685 | Published Date: Jan 2025 | No. of Page: 113 | Base Year: 2024 | Rating: 3.7 | Webstory: Check our Web story
Request Sample Report
Pre-Order Enquiry
Request Discount(%) 
1 Report Business Overview
    1.1 Study Scope
    1.2 Market Analysis by Type
        1.2.1 Global Biopharmaceutical CMO & CRO Market Size Growth Rate by Type, 2017 VS 2021 VS 2028
        1.2.2 Biologics
        1.2.3 Biosimilars
    1.3 Market by Application
        1.3.1 Global Biopharmaceutical CMO & CRO Market Size Growth Rate by Application, 2017 VS 2021 VS 2028
        1.3.2 Contract Manufacturing
        1.3.3 Contract Research
    1.4 Study Objectives
    1.5 Years Considered
2 Global Growth Trends
    2.1 Global Biopharmaceutical CMO & CRO Market Perspective (2017-2028)
    2.2 Biopharmaceutical CMO & CRO Growth Trends by Region
        2.2.1 Biopharmaceutical CMO & CRO Market Size by Region: 2017 VS 2021 VS 2028
        2.2.2 Biopharmaceutical CMO & CRO Historic Market Size by Region (2017-2022)
        2.2.3 Biopharmaceutical CMO & CRO Forecasted Market Size by Region (2023-2028)
    2.3 Biopharmaceutical CMO & CRO Market Dynamics
        2.3.1 Biopharmaceutical CMO & CRO Industry Trends
        2.3.2 Biopharmaceutical CMO & CRO Market Drivers
        2.3.3 Biopharmaceutical CMO & CRO Market Challenges
        2.3.4 Biopharmaceutical CMO & CRO Market Restraints
3 Competition Landscape by Key Players
    3.1 Global Top Biopharmaceutical CMO & CRO Players by Revenue
        3.1.1 Global Top Biopharmaceutical CMO & CRO Players by Revenue (2017-2022)
        3.1.2 Global Biopharmaceutical CMO & CRO Revenue Market Share by Players (2017-2022)
    3.2 Global Biopharmaceutical CMO & CRO Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
    3.3 Players Covered: Ranking by Biopharmaceutical CMO & CRO Revenue
    3.4 Global Biopharmaceutical CMO & CRO Market Concentration Ratio
        3.4.1 Global Biopharmaceutical CMO & CRO Market Concentration Ratio (CR5 and HHI)
        3.4.2 Global Top 10 and Top 5 Companies by Biopharmaceutical CMO & CRO Revenue in 2021
    3.5 Biopharmaceutical CMO & CRO Key Players Head office and Area Served
    3.6 Key Players Biopharmaceutical CMO & CRO Product Solution and Service
    3.7 Date of Enter into Biopharmaceutical CMO & CRO Market
    3.8 Mergers & Acquisitions, Expansion Plans
4 Biopharmaceutical CMO & CRO Breakdown Data by Type
    4.1 Global Biopharmaceutical CMO & CRO Historic Market Size by Type (2017-2022)
    4.2 Global Biopharmaceutical CMO & CRO Forecasted Market Size by Type (2023-2028)
5 Biopharmaceutical CMO & CRO Breakdown Data by Application
    5.1 Global Biopharmaceutical CMO & CRO Historic Market Size by Application (2017-2022)
    5.2 Global Biopharmaceutical CMO & CRO Forecasted Market Size by Application (2023-2028)
6 North America
    6.1 North America Biopharmaceutical CMO & CRO Market Size (2017-2028)
    6.2 North America Biopharmaceutical CMO & CRO Market Size by Type
        6.2.1 North America Biopharmaceutical CMO & CRO Market Size by Type (2017-2022)
        6.2.2 North America Biopharmaceutical CMO & CRO Market Size by Type (2023-2028)
        6.2.3 North America Biopharmaceutical CMO & CRO Market Share by Type (2017-2028)
    6.3 North America Biopharmaceutical CMO & CRO Market Size by Application
        6.3.1 North America Biopharmaceutical CMO & CRO Market Size by Application (2017-2022)
        6.3.2 North America Biopharmaceutical CMO & CRO Market Size by Application (2023-2028)
        6.3.3 North America Biopharmaceutical CMO & CRO Market Share by Application (2017-2028)
    6.4 North America Biopharmaceutical CMO & CRO Market Size by Country
        6.4.1 North America Biopharmaceutical CMO & CRO Market Size by Country (2017-2022)
        6.4.2 North America Biopharmaceutical CMO & CRO Market Size by Country (2023-2028)
        6.4.3 U.S.
        6.4.4 Canada
7 Europe
    7.1 Europe Biopharmaceutical CMO & CRO Market Size (2017-2028)
    7.2 Europe Biopharmaceutical CMO & CRO Market Size by Type
        7.2.1 Europe Biopharmaceutical CMO & CRO Market Size by Type (2017-2022)
        7.2.2 Europe Biopharmaceutical CMO & CRO Market Size by Type (2023-2028)
        7.2.3 Europe Biopharmaceutical CMO & CRO Market Share by Type (2017-2028)
    7.3 Europe Biopharmaceutical CMO & CRO Market Size by Application
        7.3.1 Europe Biopharmaceutical CMO & CRO Market Size by Application (2017-2022)
        7.3.2 Europe Biopharmaceutical CMO & CRO Market Size by Application (2023-2028)
        7.3.3 Europe Biopharmaceutical CMO & CRO Market Share by Application (2017-2028)
    7.4 Europe Biopharmaceutical CMO & CRO Market Size by Country
        7.4.1 Europe Biopharmaceutical CMO & CRO Market Size by Country (2017-2022)
        7.4.2 Europe Biopharmaceutical CMO & CRO Market Size by Country (2023-2028)
        7.4.3 Germany
        7.4.4 France
        7.4.5 U.K.
        7.4.6 Italy
        7.4.7 Russia
        7.4.8 Nordic Countries
8 Asia-Pacific
    8.1 Asia-Pacific Biopharmaceutical CMO & CRO Market Size (2017-2028)
    8.2 Asia-Pacific Biopharmaceutical CMO & CRO Market Size by Type
        8.2.1 Asia-Pacific Biopharmaceutical CMO & CRO Market Size by Type (2017-2022)
        8.2.2 Asia-Pacific Biopharmaceutical CMO & CRO Market Size by Type (2023-2028)
        8.2.3 Asia-Pacific Biopharmaceutical CMO & CRO Market Share by Type (2017-2028)
    8.3 Asia-Pacific Biopharmaceutical CMO & CRO Market Size by Application
        8.3.1 Asia-Pacific Biopharmaceutical CMO & CRO Market Size by Application (2017-2022)
        8.3.2 Asia-Pacific Biopharmaceutical CMO & CRO Market Size by Application (2023-2028)
        8.3.3 Asia-Pacific Biopharmaceutical CMO & CRO Market Share by Application (2017-2028)
    8.4 Asia-Pacific Biopharmaceutical CMO & CRO Market Size by Region
        8.4.1 Asia-Pacific Biopharmaceutical CMO & CRO Market Size by Region (2017-2022)
        8.4.2 Asia-Pacific Biopharmaceutical CMO & CRO Market Size by Region (2023-2028)
        8.4.3 China
        8.4.4 Japan
        8.4.5 South Korea
        8.4.6 Southeast Asia
        8.4.7 India
        8.4.8 Australia 
9 Latin America
    9.1 Latin America Biopharmaceutical CMO & CRO Market Size (2017-2028)
    9.2 Latin America Biopharmaceutical CMO & CRO Market Size by Type
        9.2.1 Latin America Biopharmaceutical CMO & CRO Market Size by Type (2017-2022)
        9.2.2 Latin America Biopharmaceutical CMO & CRO Market Size by Type (2023-2028)
        9.2.3 Latin America Biopharmaceutical CMO & CRO Market Share by Type (2017-2028)
    9.3 Latin America Biopharmaceutical CMO & CRO Market Size by Application
        9.3.1 Latin America Biopharmaceutical CMO & CRO Market Size by Application (2017-2022)
        9.3.2 Latin America Biopharmaceutical CMO & CRO Market Size by Application (2023-2028)
        9.3.3 Latin America Biopharmaceutical CMO & CRO Market Share by Application (2017-2028)
    9.4 Latin America Biopharmaceutical CMO & CRO Market Size by Country
        9.4.1 Latin America Biopharmaceutical CMO & CRO Market Size by Country (2017-2022)
        9.4.2 Latin America Biopharmaceutical CMO & CRO Market Size by Country (2023-2028)
        9.4.3 Mexico
        9.4.4 Brazil
10 Middle East & Africa
    10.1 Middle East & Africa Biopharmaceutical CMO & CRO Market Size (2017-2028)
    10.2 Middle East & Africa Biopharmaceutical CMO & CRO Market Size by Type
        10.2.1 Middle East & Africa Biopharmaceutical CMO & CRO Market Size by Type (2017-2022)
        10.2.2 Middle East & Africa Biopharmaceutical CMO & CRO Market Size by Type (2023-2028)
        10.2.3 Middle East & Africa Biopharmaceutical CMO & CRO Market Share by Type (2017-2028)
    10.3 Middle East & Africa Biopharmaceutical CMO & CRO Market Size by Application
        10.3.1 Middle East & Africa Biopharmaceutical CMO & CRO Market Size by Application (2017-2022)
        10.3.2 Middle East & Africa Biopharmaceutical CMO & CRO Market Size by Application (2023-2028)
        10.3.3 Middle East & Africa Biopharmaceutical CMO & CRO Market Share by Application (2017-2028)
    10.4 Middle East & Africa Biopharmaceutical CMO & CRO Market Size by Country
        10.4.1 Middle East & Africa Biopharmaceutical CMO & CRO Market Size by Country (2017-2022)
        10.4.2 Middle East & Africa Biopharmaceutical CMO & CRO Market Size by Country (2023-2028)
        10.4.3 Turkey
        10.4.4 Saudi Arabia
        10.4.5 UAE
11 Key Players Profiles
    11.1 Lonza
        11.1.1 Lonza Company Details
        11.1.2 Lonza Business Overview
        11.1.3 Lonza Biopharmaceutical CMO & CRO Introduction
        11.1.4 Lonza Revenue in Biopharmaceutical CMO & CRO Business (2017-2022)
        11.1.5 Lonza Recent Developments
    11.2 Boehringer Ingelheim GmbH
        11.2.1 Boehringer Ingelheim GmbH Company Details
        11.2.2 Boehringer Ingelheim GmbH Business Overview
        11.2.3 Boehringer Ingelheim GmbH Biopharmaceutical CMO & CRO Introduction
        11.2.4 Boehringer Ingelheim GmbH Revenue in Biopharmaceutical CMO & CRO Business (2017-2022)
        11.2.5 Boehringer Ingelheim GmbH Recent Developments
    11.3 Rentschler Biotechnologie GmbH
        11.3.1 Rentschler Biotechnologie GmbH Company Details
        11.3.2 Rentschler Biotechnologie GmbH Business Overview
        11.3.3 Rentschler Biotechnologie GmbH Biopharmaceutical CMO & CRO Introduction
        11.3.4 Rentschler Biotechnologie GmbH Revenue in Biopharmaceutical CMO & CRO Business (2017-2022)
        11.3.5 Rentschler Biotechnologie GmbH Recent Developments
    11.4 Inno Biologics Sdn Bhd
        11.4.1 Inno Biologics Sdn Bhd Company Details
        11.4.2 Inno Biologics Sdn Bhd Business Overview
        11.4.3 Inno Biologics Sdn Bhd Biopharmaceutical CMO & CRO Introduction
        11.4.4 Inno Biologics Sdn Bhd Revenue in Biopharmaceutical CMO & CRO Business (2017-2022)
        11.4.5 Inno Biologics Sdn Bhd Recent Developments
    11.5 JRS Pharma (Celonic GmbH)
        11.5.1 JRS Pharma (Celonic GmbH) Company Details
        11.5.2 JRS Pharma (Celonic GmbH) Business Overview
        11.5.3 JRS Pharma (Celonic GmbH) Biopharmaceutical CMO & CRO Introduction
        11.5.4 JRS Pharma (Celonic GmbH) Revenue in Biopharmaceutical CMO & CRO Business (2017-2022)
        11.5.5 JRS Pharma (Celonic GmbH) Recent Developments
    11.6 BIOMEVA GmbH
        11.6.1 BIOMEVA GmbH Company Details
        11.6.2 BIOMEVA GmbH Business Overview
        11.6.3 BIOMEVA GmbH Biopharmaceutical CMO & CRO Introduction
        11.6.4 BIOMEVA GmbH Revenue in Biopharmaceutical CMO & CRO Business (2017-2022)
        11.6.5 BIOMEVA GmbH Recent Developments
    11.7 ProBioGen
        11.7.1 ProBioGen Company Details
        11.7.2 ProBioGen Business Overview
        11.7.3 ProBioGen Biopharmaceutical CMO & CRO Introduction
        11.7.4 ProBioGen Revenue in Biopharmaceutical CMO & CRO Business (2017-2022)
        11.7.5 ProBioGen Recent Developments
    11.8 FUJIFILM Diosynth Biotechnologies U.S.A., Inc.
        11.8.1 FUJIFILM Diosynth Biotechnologies U.S.A., Inc. Company Details
        11.8.2 FUJIFILM Diosynth Biotechnologies U.S.A., Inc. Business Overview
        11.8.3 FUJIFILM Diosynth Biotechnologies U.S.A., Inc. Biopharmaceutical CMO & CRO Introduction
        11.8.4 FUJIFILM Diosynth Biotechnologies U.S.A., Inc. Revenue in Biopharmaceutical CMO & CRO Business (2017-2022)
        11.8.5 FUJIFILM Diosynth Biotechnologies U.S.A., Inc. Recent Developments
    11.9 TOYOBO CO., LTD
        11.9.1 TOYOBO CO., LTD Company Details
        11.9.2 TOYOBO CO., LTD Business Overview
        11.9.3 TOYOBO CO., LTD Biopharmaceutical CMO & CRO Introduction
        11.9.4 TOYOBO CO., LTD Revenue in Biopharmaceutical CMO & CRO Business (2017-2022)
        11.9.5 TOYOBO CO., LTD Recent Developments
    11.10 Samsung BioLogics
        11.10.1 Samsung BioLogics Company Details
        11.10.2 Samsung BioLogics Business Overview
        11.10.3 Samsung BioLogics Biopharmaceutical CMO & CRO Introduction
        11.10.4 Samsung BioLogics Revenue in Biopharmaceutical CMO & CRO Business (2017-2022)
        11.10.5 Samsung BioLogics Recent Developments
    11.11 Patheon
        11.11.1 Patheon Company Details
        11.11.2 Patheon Business Overview
        11.11.3 Patheon Biopharmaceutical CMO & CRO Introduction
        11.11.4 Patheon Revenue in Biopharmaceutical CMO & CRO Business (2017-2022)
        11.11.5 Patheon Recent Developments
    11.12 CMC Biologics
        11.12.1 CMC Biologics Company Details
        11.12.2 CMC Biologics Business Overview
        11.12.3 CMC Biologics Biopharmaceutical CMO & CRO Introduction
        11.12.4 CMC Biologics Revenue in Biopharmaceutical CMO & CRO Business (2017-2022)
        11.12.5 CMC Biologics Recent Developments
    11.13 Binex Co., Ltd.
        11.13.1 Binex Co., Ltd. Company Details
        11.13.2 Binex Co., Ltd. Business Overview
        11.13.3 Binex Co., Ltd. Biopharmaceutical CMO & CRO Introduction
        11.13.4 Binex Co., Ltd. Revenue in Biopharmaceutical CMO & CRO Business (2017-2022)
        11.13.5 Binex Co., Ltd. Recent Developments
    11.14 AbbVie Inc.
        11.14.1 AbbVie Inc. Company Details
        11.14.2 AbbVie Inc. Business Overview
        11.14.3 AbbVie Inc. Biopharmaceutical CMO & CRO Introduction
        11.14.4 AbbVie Inc. Revenue in Biopharmaceutical CMO & CRO Business (2017-2022)
        11.14.5 AbbVie Inc. Recent Developments
    11.15 WuXi Biologics.
        11.15.1 WuXi Biologics. Company Details
        11.15.2 WuXi Biologics. Business Overview
        11.15.3 WuXi Biologics. Biopharmaceutical CMO & CRO Introduction
        11.15.4 WuXi Biologics. Revenue in Biopharmaceutical CMO & CRO Business (2017-2022)
        11.15.5 WuXi Biologics. Recent Developments
12 Analyst's Viewpoints/Conclusions
13 Appendix
    13.1 Research Methodology
        13.1.1 Methodology/Research Approach
        13.1.2 Data Source
    13.2 Author Details
    13.3 Disclaimer
List of Tables
    Table 1. Global Biopharmaceutical CMO & CRO Market Size Growth Rate by Type (US$ Million), 2017 VS 2021 VS 2028
    Table 2. Key Players of Biologics
    Table 3. Key Players of Biosimilars
    Table 4. Global Biopharmaceutical CMO & CRO Market Size Growth Rate by Application (US$ Million), 2017 VS 2021 VS 2028
    Table 5. Global Biopharmaceutical CMO & CRO Market Size by Region (US$ Million): 2017 VS 2021 VS 2028
    Table 6. Global Biopharmaceutical CMO & CRO Market Size by Region (2017-2022) & (US$ Million)
    Table 7. Global Biopharmaceutical CMO & CRO Market Share by Region (2017-2022)
    Table 8. Global Biopharmaceutical CMO & CRO Forecasted Market Size by Region (2023-2028) & (US$ Million)
    Table 9. Global Biopharmaceutical CMO & CRO Market Share by Region (2023-2028)
    Table 10. Biopharmaceutical CMO & CRO Market Trends
    Table 11. Biopharmaceutical CMO & CRO Market Drivers
    Table 12. Biopharmaceutical CMO & CRO Market Challenges
    Table 13. Biopharmaceutical CMO & CRO Market Restraints
    Table 14. Global Biopharmaceutical CMO & CRO Revenue by Players (2017-2022) & (US$ Million)
    Table 15. Global Biopharmaceutical CMO & CRO Revenue Share by Players (2017-2022)
    Table 16. Global Top Biopharmaceutical CMO & CRO by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Biopharmaceutical CMO & CRO as of 2021)
    Table 17. Ranking of Global Top Biopharmaceutical CMO & CRO Companies by Revenue (US$ Million) in 2021
    Table 18. Global 5 Largest Players Market Share by Biopharmaceutical CMO & CRO Revenue (CR5 and HHI) & (2017-2022)
    Table 19. Key Players Headquarters and Area Served
    Table 20. Key Players Biopharmaceutical CMO & CRO Product Solution and Service
    Table 21. Date of Enter into Biopharmaceutical CMO & CRO Market
    Table 22. Mergers & Acquisitions, Expansion Plans
    Table 23. Global Biopharmaceutical CMO & CRO Market Size by Type (2017-2022) & (US$ Million)
    Table 24. Global Biopharmaceutical CMO & CRO Revenue Market Share by Type (2017-2022)
    Table 25. Global Biopharmaceutical CMO & CRO Forecasted Market Size by Type (2023-2028) & (US$ Million)
    Table 26. Global Biopharmaceutical CMO & CRO Revenue Market Share by Type (2023-2028)
    Table 27. Global Biopharmaceutical CMO & CRO Market Size by Application (2017-2022) & (US$ Million)
    Table 28. Global Biopharmaceutical CMO & CRO Revenue Share by Application (2017-2022)
    Table 29. Global Biopharmaceutical CMO & CRO Forecasted Market Size by Application (2023-2028) & (US$ Million)
    Table 30. Global Biopharmaceutical CMO & CRO Revenue Share by Application (2023-2028)
    Table 31. North America Biopharmaceutical CMO & CRO Market Size by Type (2017-2022) & (US$ Million)
    Table 32. North America Biopharmaceutical CMO & CRO Market Size by Type (2023-2028) & (US$ Million)
    Table 33. North America Biopharmaceutical CMO & CRO Market Size by Application (2017-2022) & (US$ Million)
    Table 34. North America Biopharmaceutical CMO & CRO Market Size by Application (2023-2028) & (US$ Million)
    Table 35. North America Biopharmaceutical CMO & CRO Market Size by Country (2017-2022) & (US$ Million)
    Table 36. North America Biopharmaceutical CMO & CRO Market Size by Country (2023-2028) & (US$ Million)
    Table 37. Europe Biopharmaceutical CMO & CRO Market Size by Type (2017-2022) & (US$ Million)
    Table 38. Europe Biopharmaceutical CMO & CRO Market Size by Type (2023-2028) & (US$ Million)
    Table 39. Europe Biopharmaceutical CMO & CRO Market Size by Application (2017-2022) & (US$ Million)
    Table 40. Europe Biopharmaceutical CMO & CRO Market Size by Application (2023-2028) & (US$ Million)
    Table 41. Europe Biopharmaceutical CMO & CRO Market Size by Country (2017-2022) & (US$ Million)
    Table 42. Europe Biopharmaceutical CMO & CRO Market Size by Country (2023-2028) & (US$ Million)
    Table 43. Asia Pacific Biopharmaceutical CMO & CRO Market Size by Type (2017-2022) & (US$ Million)
    Table 44. Asia Pacific Biopharmaceutical CMO & CRO Market Size by Type (2023-2028) & (US$ Million)
    Table 45. Asia Pacific Biopharmaceutical CMO & CRO Market Size by Application (2017-2022) & (US$ Million)
    Table 46. Asia Pacific Biopharmaceutical CMO & CRO Market Size by Application (2023-2028) & (US$ Million)
    Table 47. Asia Pacific Biopharmaceutical CMO & CRO Market Size by Region (2017-2022) & (US$ Million)
    Table 48. Asia Pacific Biopharmaceutical CMO & CRO Market Size by Region (2023-2028) & (US$ Million)
    Table 49. Latin America Biopharmaceutical CMO & CRO Market Size by Type (2017-2022) & (US$ Million)
    Table 50. Latin America Biopharmaceutical CMO & CRO Market Size by Type (2023-2028) & (US$ Million)
    Table 51. Latin America Biopharmaceutical CMO & CRO Market Size by Application (2017-2022) & (US$ Million)
    Table 52. Latin America Biopharmaceutical CMO & CRO Market Size by Application (2023-2028) & (US$ Million)
    Table 53. Latin America Biopharmaceutical CMO & CRO Market Size by Country (2017-2022) & (US$ Million)
    Table 54. Latin America Biopharmaceutical CMO & CRO Market Size by Country (2023-2028) & (US$ Million)
    Table 55. Middle East and Africa Biopharmaceutical CMO & CRO Market Size by Type (2017-2022) & (US$ Million)
    Table 56. Middle East and Africa Biopharmaceutical CMO & CRO Market Size by Type (2023-2028) & (US$ Million)
    Table 57. Middle East and Africa Biopharmaceutical CMO & CRO Market Size by Application (2017-2022) & (US$ Million)
    Table 58. Middle East and Africa Biopharmaceutical CMO & CRO Market Size by Application (2023-2028) & (US$ Million)
    Table 59. Middle East and Africa Biopharmaceutical CMO & CRO Market Size by Country (2017-2022) & (US$ Million)
    Table 60. Middle East and Africa Biopharmaceutical CMO & CRO Market Size by Country (2023-2028) & (US$ Million)
    Table 61. Lonza Company Details
    Table 62. Lonza Business Overview
    Table 63. Lonza Biopharmaceutical CMO & CRO Product
    Table 64. Lonza Revenue in Biopharmaceutical CMO & CRO Business (2017-2022) & (US$ Million)
    Table 65. Lonza Recent Developments
    Table 66. Boehringer Ingelheim GmbH Company Details
    Table 67. Boehringer Ingelheim GmbH Business Overview
    Table 68. Boehringer Ingelheim GmbH Biopharmaceutical CMO & CRO Product
    Table 69. Boehringer Ingelheim GmbH Revenue in Biopharmaceutical CMO & CRO Business (2017-2022) & (US$ Million)
    Table 70. Boehringer Ingelheim GmbH Recent Developments
    Table 71. Rentschler Biotechnologie GmbH Company Details
    Table 72. Rentschler Biotechnologie GmbH Business Overview
    Table 73. Rentschler Biotechnologie GmbH Biopharmaceutical CMO & CRO Product
    Table 74. Rentschler Biotechnologie GmbH Revenue in Biopharmaceutical CMO & CRO Business (2017-2022) & (US$ Million)
    Table 75. Rentschler Biotechnologie GmbH Recent Developments
    Table 76. Inno Biologics Sdn Bhd Company Details
    Table 77. Inno Biologics Sdn Bhd Business Overview
    Table 78. Inno Biologics Sdn Bhd Biopharmaceutical CMO & CRO Product
    Table 79. Inno Biologics Sdn Bhd Revenue in Biopharmaceutical CMO & CRO Business (2017-2022) & (US$ Million)
    Table 80. Inno Biologics Sdn Bhd Recent Developments
    Table 81. JRS Pharma (Celonic GmbH) Company Details
    Table 82. JRS Pharma (Celonic GmbH) Business Overview
    Table 83. JRS Pharma (Celonic GmbH) Biopharmaceutical CMO & CRO Product
    Table 84. JRS Pharma (Celonic GmbH) Revenue in Biopharmaceutical CMO & CRO Business (2017-2022) & (US$ Million)
    Table 85. JRS Pharma (Celonic GmbH) Recent Developments
    Table 86. BIOMEVA GmbH Company Details
    Table 87. BIOMEVA GmbH Business Overview
    Table 88. BIOMEVA GmbH Biopharmaceutical CMO & CRO Product
    Table 89. BIOMEVA GmbH Revenue in Biopharmaceutical CMO & CRO Business (2017-2022) & (US$ Million)
    Table 90. BIOMEVA GmbH Recent Developments
    Table 91. ProBioGen Company Details
    Table 92. ProBioGen Business Overview
    Table 93. ProBioGen Biopharmaceutical CMO & CRO Product
    Table 94. ProBioGen Revenue in Biopharmaceutical CMO & CRO Business (2017-2022) & (US$ Million)
    Table 95. ProBioGen Recent Developments
    Table 96. FUJIFILM Diosynth Biotechnologies U.S.A., Inc. Company Details
    Table 97. FUJIFILM Diosynth Biotechnologies U.S.A., Inc. Business Overview
    Table 98. FUJIFILM Diosynth Biotechnologies U.S.A., Inc. Biopharmaceutical CMO & CRO Product
    Table 99. FUJIFILM Diosynth Biotechnologies U.S.A., Inc. Revenue in Biopharmaceutical CMO & CRO Business (2017-2022) & (US$ Million)
    Table 100. FUJIFILM Diosynth Biotechnologies U.S.A., Inc. Recent Developments
    Table 101. TOYOBO CO., LTD Company Details
    Table 102. TOYOBO CO., LTD Business Overview
    Table 103. TOYOBO CO., LTD Biopharmaceutical CMO & CRO Product
    Table 104. TOYOBO CO., LTD Revenue in Biopharmaceutical CMO & CRO Business (2017-2022) & (US$ Million)
    Table 105. TOYOBO CO., LTD Recent Developments
    Table 106. Samsung BioLogics Company Details
    Table 107. Samsung BioLogics Business Overview
    Table 108. Samsung BioLogics Biopharmaceutical CMO & CRO Product
    Table 109. Samsung BioLogics Revenue in Biopharmaceutical CMO & CRO Business (2017-2022) & (US$ Million)
    Table 110. Samsung BioLogics Recent Developments
    Table 111. Patheon Company Details
    Table 112. Patheon Business Overview
    Table 113. Patheon Biopharmaceutical CMO & CRO Product
    Table 114. Patheon Revenue in Biopharmaceutical CMO & CRO Business (2017-2022) & (US$ Million)
    Table 115. Patheon Recent Developments
    Table 116. CMC Biologics Company Details
    Table 117. CMC Biologics Business Overview
    Table 118. CMC Biologics Biopharmaceutical CMO & CRO Product
    Table 119. CMC Biologics Revenue in Biopharmaceutical CMO & CRO Business (2017-2022) & (US$ Million)
    Table 120. CMC Biologics Recent Developments
    Table 121. Binex Co., Ltd. Company Details
    Table 122. Binex Co., Ltd. Business Overview
    Table 123. Binex Co., Ltd. Biopharmaceutical CMO & CRO Product
    Table 124. Binex Co., Ltd. Revenue in Biopharmaceutical CMO & CRO Business (2017-2022) & (US$ Million)
    Table 125. Binex Co., Ltd. Recent Developments
    Table 126. AbbVie Inc. Company Details
    Table 127. AbbVie Inc. Business Overview
    Table 128. AbbVie Inc. Biopharmaceutical CMO & CRO Product
    Table 129. AbbVie Inc. Revenue in Biopharmaceutical CMO & CRO Business (2017-2022) & (US$ Million)
    Table 130. AbbVie Inc. Recent Developments
    Table 131. WuXi Biologics. Company Details
    Table 132. WuXi Biologics. Business Overview
    Table 133. WuXi Biologics. Biopharmaceutical CMO & CRO Product
    Table 134. WuXi Biologics. Revenue in Biopharmaceutical CMO & CRO Business (2017-2022) & (US$ Million)
    Table 135. WuXi Biologics. Recent Developments
    Table 136. Research Programs/Design for This Report
    Table 137. Key Data Information from Secondary Sources
    Table 138. Key Data Information from Primary Sources
List of Figures
    Figure 1. Global Biopharmaceutical CMO & CRO Market Share by Type: 2021 VS 2028
    Figure 2. Biologics Features
    Figure 3. Biosimilars Features
    Figure 4. Global Biopharmaceutical CMO & CRO Market Share by Application: 2021 VS 2028
    Figure 5. Contract Manufacturing Case Studies
    Figure 6. Contract Research Case Studies
    Figure 7. Biopharmaceutical CMO & CRO Report Years Considered
    Figure 8. Global Biopharmaceutical CMO & CRO Market Size (US$ Million), Year-over-Year: 2017-2028
    Figure 9. Global Biopharmaceutical CMO & CRO Market Size, (US$ Million), 2017 VS 2021 VS 2028
    Figure 10. Global Biopharmaceutical CMO & CRO Market Share by Region: 2021 VS 2028
    Figure 11. Global Biopharmaceutical CMO & CRO Market Share by Players in 2021
    Figure 12. Global Top Biopharmaceutical CMO & CRO Players by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Biopharmaceutical CMO & CRO as of 2021)
    Figure 13. The Top 10 and 5 Players Market Share by Biopharmaceutical CMO & CRO Revenue in 2021
    Figure 14. North America Biopharmaceutical CMO & CRO Market Size YoY (2017-2028) & (US$ Million)
    Figure 15. North America Biopharmaceutical CMO & CRO Market Size Market Share by Type (2017-2028)
    Figure 16. North America Biopharmaceutical CMO & CRO Market Size Market Share by Application (2017-2028)
    Figure 17. North America Biopharmaceutical CMO & CRO Market Size Share by Country (2017-2028)
    Figure 18. United States Biopharmaceutical CMO & CRO Market Size YoY Growth (2017-2028) & (US$ Million)
    Figure 19. Canada Biopharmaceutical CMO & CRO Market Size YoY Growth (2017-2028) & (US$ Million)
    Figure 20. Europe Biopharmaceutical CMO & CRO Market Size YoY (2017-2028) & (US$ Million)
    Figure 21. Europe Biopharmaceutical CMO & CRO Market Size Market Share by Type (2017-2028)
    Figure 22. Europe Biopharmaceutical CMO & CRO Market Size Market Share by Application (2017-2028)
    Figure 23. Europe Biopharmaceutical CMO & CRO Market Size Share by Country (2017-2028)
    Figure 24. Germany Biopharmaceutical CMO & CRO Market Size YoY Growth (2017-2028) & (US$ Million)
    Figure 25. France Biopharmaceutical CMO & CRO Market Size YoY Growth (2017-2028) & (US$ Million)
    Figure 26. U.K. Biopharmaceutical CMO & CRO Market Size YoY Growth (2017-2028) & (US$ Million)
    Figure 27. Italy Biopharmaceutical CMO & CRO Market Size YoY Growth (2017-2028) & (US$ Million)
    Figure 28. Russia Biopharmaceutical CMO & CRO Market Size YoY Growth (2017-2028) & (US$ Million)
    Figure 29. Nordic Countries Biopharmaceutical CMO & CRO Market Size YoY Growth (2017-2028) & (US$ Million)
    Figure 30. Asia-Pacific Biopharmaceutical CMO & CRO Market Size YoY (2017-2028) & (US$ Million)
    Figure 31. Asia Pacific Biopharmaceutical CMO & CRO Market Size Market Share by Type (2017-2028)
    Figure 32. Asia Pacific Biopharmaceutical CMO & CRO Market Size Market Share by Application (2017-2028)
    Figure 33. Asia Pacific Biopharmaceutical CMO & CRO Market Size Share by Region (2017-2028)
    Figure 34. China Biopharmaceutical CMO & CRO Market Size YoY Growth (2017-2028) & (US$ Million)
    Figure 35. Japan Biopharmaceutical CMO & CRO Market Size YoY Growth (2017-2028) & (US$ Million)
    Figure 36. South Korea Biopharmaceutical CMO & CRO Market Size YoY Growth (2017-2028) & (US$ Million)
    Figure 37. Southeast Asia Biopharmaceutical CMO & CRO Market Size YoY Growth (2017-2028) & (US$ Million)
    Figure 38. India Biopharmaceutical CMO & CRO Market Size YoY Growth (2017-2028) & (US$ Million)
    Figure 39. Australia Biopharmaceutical CMO & CRO Market Size YoY Growth (2017-2028) & (US$ Million)
List of Figures
    Figure 40. Latin America Biopharmaceutical CMO & CRO Market Size YoY (2017-2028) & (US$ Million)
    Figure 41. Latin America Biopharmaceutical CMO & CRO Market Size Market Share by Type (2017-2028)
    Figure 42. Latin America Biopharmaceutical CMO & CRO Market Size Market Share by Application (2017-2028)
    Figure 43. Latin America Biopharmaceutical CMO & CRO Market Size Share by Country (2017-2028)
    Figure 44. Mexico Biopharmaceutical CMO & CRO Market Size YoY Growth (2017-2028) & (US$ Million)
    Figure 45. Brazil Biopharmaceutical CMO & CRO Market Size YoY Growth (2017-2028) & (US$ Million)
    Figure 46. Middle East & Africa Biopharmaceutical CMO & CRO Market Size YoY (2017-2028) & (US$ Million)
    Figure 47. Middle East and Africa Biopharmaceutical CMO & CRO Market Size Market Share by Type (2017-2028)
    Figure 48. Middle East and Africa Biopharmaceutical CMO & CRO Market Size Market Share by Application (2017-2028)
    Figure 49. Middle East and Africa Biopharmaceutical CMO & CRO Market Size Share by Country (2017-2028)
    Figure 50. Turkey Biopharmaceutical CMO & CRO Market Size YoY Growth (2017-2028) & (US$ Million)
    Figure 51. Saudi Arabia Biopharmaceutical CMO & CRO Market Size YoY Growth (2017-2028) & (US$ Million)
    Figure 52. UAE Biopharmaceutical CMO & CRO Market Size YoY Growth (2017-2028) & (US$ Million)
    Figure 53. Lonza Revenue Growth Rate in Biopharmaceutical CMO & CRO Business (2017-2022)
    Figure 54. Boehringer Ingelheim GmbH Revenue Growth Rate in Biopharmaceutical CMO & CRO Business (2017-2022)
    Figure 55. Rentschler Biotechnologie GmbH Revenue Growth Rate in Biopharmaceutical CMO & CRO Business (2017-2022)
    Figure 56. Inno Biologics Sdn Bhd Revenue Growth Rate in Biopharmaceutical CMO & CRO Business (2017-2022)
    Figure 57. JRS Pharma (Celonic GmbH) Revenue Growth Rate in Biopharmaceutical CMO & CRO Business (2017-2022)
    Figure 58. BIOMEVA GmbH Revenue Growth Rate in Biopharmaceutical CMO & CRO Business (2017-2022)
    Figure 59. ProBioGen Revenue Growth Rate in Biopharmaceutical CMO & CRO Business (2017-2022)
    Figure 60. FUJIFILM Diosynth Biotechnologies U.S.A., Inc. Revenue Growth Rate in Biopharmaceutical CMO & CRO Business (2017-2022)
    Figure 61. TOYOBO CO., LTD Revenue Growth Rate in Biopharmaceutical CMO & CRO Business (2017-2022)
    Figure 62. Samsung BioLogics Revenue Growth Rate in Biopharmaceutical CMO & CRO Business (2017-2022)
    Figure 63. Patheon Revenue Growth Rate in Biopharmaceutical CMO & CRO Business (2017-2022)
    Figure 64. CMC Biologics Revenue Growth Rate in Biopharmaceutical CMO & CRO Business (2017-2022)
    Figure 65. Binex Co., Ltd. Revenue Growth Rate in Biopharmaceutical CMO & CRO Business (2017-2022)
    Figure 66. AbbVie Inc. Revenue Growth Rate in Biopharmaceutical CMO & CRO Business (2017-2022)
    Figure 67. WuXi Biologics. Revenue Growth Rate in Biopharmaceutical CMO & CRO Business (2017-2022)
    Figure 68. Bottom-up and Top-down Approaches for This Report
    Figure 69. Data Triangulation
    Figure 70. Key Executives Interviewed
Please ask for List of Figures. Request Sample Report
Companies Included in Reports:
Lonza
Boehringer Ingelheim GmbH
Rentschler Biotechnologie GmbH
Inno Biologics Sdn Bhd
JRS Pharma (Celonic GmbH)
BIOMEVA GmbH
ProBioGen
FUJIFILM Diosynth Biotechnologies U.S.A., Inc.
TOYOBO CO., LTD
Samsung BioLogics
Patheon
CMC Biologics
Binex Co., Ltd.
AbbVie Inc.
WuXi Biologics.
Frequently Asked Questions
Biopharmaceutical CMO & CRO report offers great insights of the market and consumer data and their interpretation through various figures and graphs. Report has embedded global market and regional market deep analysis through various research methodologies. The report also offers great competitor analysis of the industries and highlights the key aspect of their business like success stories, market development and growth rate.
Biopharmaceutical CMO & CRO report is categorised based on following features:
  1. Global Market Players
  2. Geopolitical regions
  3. Consumer Insights
  4. Technological advancement
  5. Historic and Future Analysis of the Market
Biopharmaceutical CMO & CRO report is designed on the six basic aspects of analysing the market, which covers the SWOT and SWAR analysis like strength, weakness, opportunity, threat, aspirations and results. This methodology helps investors to reach on to the desired and correct decision to put their capital into the market.

Related Reports

Bonded Carbide

Bonded Carbide market is segmented by Type and by Application. Players, stakeholders, and other p ... Read More